Literature DB >> 8599154

Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement.

O Sandgren1.   

Abstract

The complex of diseases referred to as amyloidosis is characterized by the deposition of amyloid substance in various tissues. The amyloid protein differs in the various forms of amyloidosis. This variation is the basis of the differences in affected tissues and subsequent clinical dissimilarities. Vitreous involvement in amyloidosis seems to be especially linked to some of the hereditary neuropathies associated with the amyloid protein transthyretin. Characterization of the amyloid proteins during recent decades has allowed a chemical and immunologic classification of amyloid fibrils. This paper presents the basis for classification of amyloidosis, reviews the literature on ocular amyloidosis, with special reference to vitreous involvement, and summarizes clinical findings and frequency of vitreous amyloid involvement in Swedish patients with familial amyloidotic polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8599154     DOI: 10.1016/s0039-6257(95)80025-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  18 in total

1.  [Bilateral vitreous opacities].

Authors:  M J M Groh; U Schönherr
Journal:  Ophthalmologe       Date:  2002-03       Impact factor: 1.059

2.  [Refractory pseudofollicular conjunctivitis].

Authors:  R Khatib; H Göbel; C Kurschat; C Röcken; C Cursiefen; P Steven; L M Heindl
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

3.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea.

Authors:  K Araki-Sasaki; Y Ando; M Nakamura; K Kitagawa; S Ikemizu; T Kawaji; T Yamashita; M Ueda; K Hirano; M Yamada; K Matsumoto; S Kinoshita; H Tanihara
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.

Authors:  Hsi-Kung Kuo; Yi-Hao Chen; Faye Huang; Yi-Chan Wu; Jentaie Shiea; Pei-Chang Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

6.  Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.

Authors:  W Lv; J Chen; W Chen; P Hou; C P Pang; H Chen
Journal:  Eye (Lond)       Date:  2014-01-31       Impact factor: 3.775

7.  [Conjunctival amyloidosis].

Authors:  Katerina Hufendiek; K Hufendiek; L Metzger; P Rümmele; J Pfirstinger; H Helbig; M-A Gamulescu
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

Review 8.  Monoclonal origin of localised orbital amyloidosis detected by molecular analysis.

Authors:  S Pasternak; V A White; R D Gascoyne; S R Perry; R L Johnson; J Rootman
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

9.  Indocyanine green angiography findings in patients with nonfamilial amyloidosis.

Authors:  Sonia Attia; Rim Kahloun; Sameh Mbarek; Olfa Harazallah; Habib Skhiri; Salim Ben Yahia; Moncef Khairallah
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-24

10.  Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient.

Authors:  Mariana Seca; Natália Ferreira; Teresa Coelho
Journal:  Case Rep Ophthalmol       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.